How to Help Your Patients Save Money on Cobenfy: A Provider's Guide to Savings Programs

Author

Peter Daggett

Summarize with AI

Why Cost Assistance Matters More for Cobenfy
Program 1: COBENFY Co-Pay Assistance Program (Commercially Insured Patients)
Program 2: COBENFY Cares — Full Patient Support Hub
Program 3: 4-Week Starter Pack — Bridge During PA Processing
Program 4: Medicare Navigation — Part D and Extra Help
Program 5: Patient Assistance Program (PAP) for Uninsured and Underinsured Patients
Program 6: Medicaid Coverage
Building a Streamlined Access Workflow in Your Practice
Key Contacts and Resources

Provider guide to Cobenfy savings: COBENFY Cares co-pay card, Medicare navigation, PAP referrals, and how your practice can help patients afford their prescription.

Cobenfy's list price of approximately $1,887/month is a significant barrier for many patients with schizophrenia. As a prescriber, your role extends beyond writing the prescription — helping your patients navigate the financial landscape of a new specialty medication is essential to ensuring they actually start and stay on treatment. This guide covers every savings program available for Cobenfy and how your practice can streamline the process.

Why Cost Assistance Matters More for Cobenfy

Patients with schizophrenia face disproportionate financial barriers to medication access. Many have reduced employment capacity due to their illness, and a significant proportion are on public assistance or disability income. With Cobenfy priced as a specialty drug at $1,887/month, cost is one of the top barriers to initiation and adherence — even when the clinical decision to prescribe is clear. Proactively connecting patients with savings programs at the point of prescribing dramatically improves treatment uptake.

Program 1: COBENFY Co-Pay Assistance Program (Commercially Insured Patients)

This is the most impactful program for your commercially insured patients. Eligible patients with commercial (employer or private) insurance may pay as little as $0 per 30-day supply through the COBENFY Co-Pay Assistance Program.

Eligibility criteria:

Patient has commercial or private health insurance
Insurance does not fully cover Cobenfy
Patient does NOT have government insurance (Medicare, Medicaid, TRICARE, VA)
Patient is a U.S. resident

How patients enroll: Patients visit cobenfy.com/co-pay-assistance-program or call 1-877-262-3639. As a prescriber, you can facilitate this enrollment at the time of the office visit by providing the COBENFY Cares contact information and encouraging same-day enrollment.

Program 2: COBENFY Cares — Full Patient Support Hub

COBENFY Cares (1-877-262-3639, cobenfy.com/support-program) is the comprehensive patient support program from Bristol Myers Squibb. For your practice, COBENFY Cares offers:

Prior authorization assistance and appeals support on behalf of your patients
Benefit verification services (checking your patient's insurance coverage before you prescribe)
Specialty pharmacy coordination
Patient assistance program (PAP) referrals for uninsured and underinsured patients
Patient education and adherence support resources (24/7)

Program 3: 4-Week Starter Pack — Bridge During PA Processing

BMS provides 4-week starter pack vouchers that allow your newly initiated patients to begin Cobenfy immediately — before insurance PA is approved. This prevents treatment gaps and ensures patients complete the titration phase even if coverage decisions are delayed. Contact your BMS field representative or COBENFY Cares at 1-877-262-3639 to request starter pack vouchers for your office.

For your Medicare patients, the savings landscape is structured differently:

Medicare Extra Help (LIS): Patients with limited income and resources who qualify for the Social Security Administration's Extra Help program pay no more than $12.15/month for Cobenfy (2025 rate). Refer eligible patients to SSA.gov or 1-800-772-1213 to apply.
Medicare Part D $2,000 cap: Starting in 2025, all Medicare Part D plans have a $2,000 annual out-of-pocket maximum. This significantly limits total annual costs for specialty drugs like Cobenfy, even without Extra Help.
Formulary placement: Many Medicare Part D plans cover Cobenfy, typically at a specialty tier. COBENFY Cares can verify your specific patient's Part D plan coverage before you prescribe.

Program 5: Patient Assistance Program (PAP) for Uninsured and Underinsured Patients

For patients without adequate insurance coverage who meet income requirements, a Patient Assistance Program may provide Cobenfy at no cost or significantly reduced cost. PAP applications are typically handled through the manufacturer's support program. Refer your qualifying patients to COBENFY Cares at 1-877-262-3639 to determine eligibility and initiate the application.

Program 6: Medicaid Coverage

Medicaid coverage for Cobenfy varies by state. Some states have added it to their preferred drug lists (PDL) with minimal barriers; others require prior authorization or may not yet cover it. Encourage patients on Medicaid to contact their state's program directly, and note that COBENFY Cares can also provide state-specific Medicaid coverage information.

Building a Streamlined Access Workflow in Your Practice

The most effective practices have built a simple workflow for Cobenfy prescribing:

Pre-prescribing: Use COBENFY Cares for benefits verification — confirm insurance coverage before the patient leaves your office
At prescribing: Provide the COBENFY Cares card/phone number; hand off a starter pack voucher if available; complete PA paperwork before end of visit when possible
For uninsured/underinsured patients: Route directly to COBENFY Cares PAP program; ensure patients know cost is not an absolute barrier
Follow-up: Check in at 2-week appointment whether patient has successfully filled; troubleshoot PA, specialty pharmacy, or cost issues proactively

Key Contacts and Resources

COBENFY Cares (patient and provider): 1-877-COBENFY (1-877-262-3639), 24/7
HCP portal: cobenfyhcp.com/support
Medicare Extra Help application: SSA.gov/extrahelp or 1-800-772-1213
Medfinder for Providers (medfinder.com/providers) — check real-time pharmacy stock to direct patients to in-stock locations

For additional guidance on managing Cobenfy access and shortage-related challenges for your patients, see our Cobenfy provider shortage guide.

Frequently Asked Questions

Providers can direct commercially insured patients to the BMS copay assistance program, which can reduce costs to $0. For uninsured or underinsured patients, the BMS patient assistance program may provide Cobenfy at no cost. Providers can also help patients appeal insurance denials and navigate prior authorization requirements.

With commercial insurance or Medicare Part D coverage, patients typically pay $0 to $50 per month in copays. However, Cobenfy is usually placed on Tier 4 or Tier 5 specialty tiers, meaning copays can be higher without the BMS copay assistance program. Prior authorization is almost always required.

Providers can help patients initiate enrollment, but patients typically complete the process themselves through the BMS website or phone line. Providers can support by providing necessary clinical documentation, writing letters of medical necessity for insurance appeals, and connecting patients with pharmacy benefit specialists.

Submit a peer-to-peer review with the insurance medical director, provide additional clinical documentation supporting medical necessity, file a formal appeal, and explore the BMS patient assistance program as a bridge while the appeal is processed. Document that the patient has schizophrenia and explain why Cobenfy is preferred over alternatives.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards